Immortalized cardiac stem cells for cardiac repair

ES3077396T3Undetermined Publication Date: 2026-08-31SECRETOME THERAPEUTICS INC +1

View PDF 0 Cites 0 Cited by

Patent Information

Application Number: ES2022215642T
Authority / Receiving Office: ES · ES
Patent Type: Patents
Current Assignee / Owner
Priority Date: 2019-11-15
Filing Date: 2020-11-13
Publication Date: 2026-08-31
Estimated Expiration: 2040-11-13

Application Information

Patent Timeline

15 Nov 2019

Priority

13 Nov 2020

Application

ES2022215642T

31 Aug 2026

Publication

ES3077396T3

IPC: A61K35/34; A61P9/04; A61P9/10; A61P17/02; C12N5/077

CPC: A61K35/34; A61P9/04; A61P9/10; A61P17/02; C12N5/0657; C12N2501/599; C12N2510/00; C12N2510/04

Inventors: MISHRA Rachana; KARATHANASIS Sotirios K.

Get more patent work done with AI

Run novelty searches—or use them for FTO, design risk, drafting and technical problem-solving.

Explore More Agents

Novelty Search
Search existing technologies and assess novelty
↗
FTO
Analyze whether a product may infringe others' patents
↗
Design FTO
Check prior-design risk for exterior design
↗
Drafting
Draft patent application text based on a technical solution
↗
Find Solutions with TRIZ
Generate feasible solution to solve your technical challenge
↗
IP MCP Servers
Connect trusted patent search and cited evidence to Claude, Cursor or your own AI workflow
↗

Patent Text Reader

Abstract

A pharmaceutical composition comprising IGF-1 and one or more paracrine factors selected from the group consisting of Ang-1, HGF, SDF-1, VEGF-A, bFGF, PDGF-B, and SCF14; wherein the pharmaceutical composition is a solution comprising a conditioned medium.

Need to check novelty before this filing date? Find Prior Art